RNTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aileron Therapeutics Inc (RNTX).


$49.83M Market Cap.

As of 04/08/2025 5:00 PM ET (MRY) • Disclaimer

RNTX Market Cap. (MRY)


RNTX Shares Outstanding (MRY)


RNTX Assets (MRY)


Total Assets

$62.19M

Total Liabilities

$7.80M

Total Investments

$0

RNTX Income (MRY)


Revenue

$0

Net Income

-$62.88M

Operating Expense

$65.11M

RNTX Cash Flow (MRY)


CF Operations

-$22.29M

CF Investing

$0

CF Financing

$17.82M

RNTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

RNTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$62,190,000 (-41.33%)

$106,008,000 (381.70%)

$22,007,000 (-54.61%)

$48,481,000 (196.68%)

Assets Current

$13,657,000 (-25.23%)

$18,266,000 (-16.49%)

$21,873,000 (-54.60%)

$48,177,000 (195.09%)

Assets Non-Current

$48,533,000 (-44.69%)

$87,742,000 (65379.10%)

$134,000 (-55.92%)

$304,000 (1926.67%)

Goodwill & Intangible Assets

$48,530,000 (-43.26%)

$85,530,000 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$54,392,000 (-44.67%)

$98,297,000 (427.83%)

$18,623,000 (-57.58%)

$43,904,000 (260.99%)

Property Plant & Equipment Net

$1,000 (-94.74%)

$19,000 (-82.73%)

$110,000 (-60.71%)

$280,000 (1766.67%)

Cash & Equivalents

$12,865,000 (-25.80%)

$17,338,000 (232.21%)

$5,219,000 (43.97%)

$3,625,000 (-52.55%)

Accumulated Other Comprehensive Income

-$18,000 (71.43%)

-$63,000 (-31.25%)

-$48,000 (-269.23%)

-$13,000 (-550.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$16,048,000 (-62.09%)

$42,333,000 (526.32%)

Investments Current

$0 (0%)

$0 (0%)

$16,048,000 (-62.09%)

$42,333,000 (526.32%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$911,000 (-23.45%)

$1,190,000 (-30.81%)

$1,720,000 (42.15%)

$1,210,000 (-24.19%)

Accumulated Retained Earnings (Deficit)

-$351,400,000 (-21.80%)

-$288,517,000 (-5.77%)

-$272,785,000 (-11.13%)

-$245,456,000 (-11.93%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$1,772,000 (-46.72%)

$3,326,000 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$48,000 (45.45%)

$33,000 (-79.63%)

$162,000 (-58.14%)

Debt Current

$0 (0%)

$48,000 (45.45%)

$33,000 (-64.52%)

$93,000 (-44.64%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$69,000 (-68.49%)

Total Liabilities

$7,798,000 (1.13%)

$7,711,000 (127.87%)

$3,384,000 (-26.07%)

$4,577,000 (9.52%)

Liabilities Current

$5,749,000 (31.11%)

$4,385,000 (29.58%)

$3,384,000 (-24.93%)

$4,508,000 (13.84%)

Liabilities Non-Current

$2,049,000 (-38.39%)

$3,326,000 (0%)

$0 (0%)

$69,000 (-68.49%)

RNTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$13,864,000 (22.07%)

$11,357,000 (17.32%)

$9,680,000 (0.86%)

$9,597,000 (2.86%)

Research & Development Expense

$14,248,000 (257.00%)

$3,991,000 (-77.79%)

$17,967,000 (5.64%)

$17,008,000 (52.32%)

Operating Expenses

$65,112,000 (300.05%)

$16,276,000 (-41.13%)

$27,647,000 (3.92%)

$26,605,000 (29.81%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$1,544,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$62,883,000 (-299.71%)

-$15,732,000 (42.43%)

-$27,329,000 (-4.45%)

-$26,164,000 (-23.67%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$62,883,000 (-299.71%)

-$15,732,000 (42.43%)

-$27,329,000 (-4.45%)

-$26,164,000 (-23.67%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$62,883,000 (-299.71%)

-$15,732,000 (42.43%)

-$27,329,000 (-4.45%)

-$26,164,000 (-23.67%)

Weighted Average Shares

$17,938,899 (290.09%)

$4,598,715 (1.31%)

$4,539,318 (2.23%)

$4,440,338 (154.70%)

Weighted Average Shares Diluted

$17,938,899 (290.09%)

$4,598,715 (1.31%)

$4,539,318 (2.23%)

$4,440,338 (154.70%)

Earning Before Interest & Taxes (EBIT)

-$64,427,000 (-309.53%)

-$15,732,000 (42.43%)

-$27,329,000 (-4.45%)

-$26,164,000 (-23.67%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$65,112,000 (-300.05%)

-$16,276,000 (41.13%)

-$27,647,000 (-3.92%)

-$26,605,000 (-29.81%)

RNTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$16,196,000 (-38.79%)

$26,459,000 (173.67%)

-$35,917,000 (-660.24%)

Net Cash Flow from Financing

$17,818,000 (12.81%)

$15,794,000 (0%)

$0 (0%)

$55,657,000 (252.26%)

Net Cash Flow from Operations

-$22,291,000 (-12.54%)

-$19,808,000 (20.34%)

-$24,865,000 (-4.68%)

-$23,754,000 (-16.01%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,473,000 (-136.91%)

$12,119,000 (660.29%)

$1,594,000 (139.71%)

-$4,014,000 (-331.35%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$96,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$16,250,000 (-38.58%)

$26,459,000 (173.85%)

-$35,826,000 (-677.09%)

Capital Expenditure

$0 (0%)

$42,000 (0%)

$0 (0%)

-$91,000 (-144.83%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$15,794,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$10,788,000 (0%)

$0 (0%)

$0 (0%)

$55,657,000 (261.10%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

-$63,000 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,117,000 (-6.13%)

$1,190,000 (-42.87%)

$2,083,000 (-7.83%)

$2,260,000 (19.39%)

Depreciation Amortization & Accretion

$63,000 (-47.06%)

$119,000 (-29.59%)

$169,000 (39.67%)

$121,000 (-25.77%)

RNTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-73.60% (-59.65%)

-46.10% (55.29%)

-103.10% (-108.28%)

-49.50% (70.14%)

Return on Average Assets (ROAA)

-67.10% (-59.76%)

-42.00% (52.65%)

-88.70% (-93.67%)

-45.80% (53.97%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

1657.40% (204.67%)

-1583.50% (-1075.58%)

-134.70% (-121.18%)

-60.90% (73.35%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.66 (26.49%)

-0.89 (-126.14%)

-0.39 (79.38%)

-1.91 (-12.08%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

0.92 (549.65%)

0.14 (-75.61%)

0.58 (-50.22%)

1.16 (-66.63%)

Debt to Equity Ratio (D/E)

0.14 (83.33%)

0.08 (-57.14%)

0.18 (75.00%)

0.1 (-69.77%)

Earnings Per Share (EPS)

-3.51 (-2.63%)

-3.42 (43.19%)

-6.02 (-2.21%)

-5.89 (51.72%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.24 (71.08%)

-4.3 (21.54%)

-5.48 (-2.01%)

-5.37 (53.82%)

Book Value Per Share (BVPS)

3.03 (-85.82%)

21.38 (420.96%)

4.1 (-58.51%)

9.89 (41.74%)

Tangible Assets Book Value Per Share (TABVPS)

0.76 (-82.91%)

4.45 (-8.15%)

4.85 (-55.60%)

10.92 (16.48%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

0 (0%)

-2 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.5 (-346.43%)

-0.11 (49.09%)

-0.22 (86.84%)

-1.67 (11.21%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2.38 (-42.97%)

4.17 (-35.55%)

6.46 (-39.52%)

10.69 (159.20%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$22,291,000 (-12.77%)

-$19,766,000 (20.51%)

-$24,865,000 (-4.28%)

-$23,845,000 (-17.62%)

Enterprise Value (EV)

$32,154,664 (1737.20%)

$1,750,202 (-70.66%)

$5,965,596 (-86.30%)

$43,547,878 (10.17%)

Earnings Before Tax (EBT)

-$64,427,000 (-309.53%)

-$15,732,000 (42.43%)

-$27,329,000 (-4.45%)

-$26,164,000 (-23.67%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$64,364,000 (-312.25%)

-$15,613,000 (42.51%)

-$27,160,000 (-4.29%)

-$26,043,000 (-24.05%)

Invested Capital

-$4,954,000 (-313.87%)

-$1,197,000 (-108.91%)

$13,437,000 (-66.83%)

$40,510,000 (689.82%)

Working Capital

$7,908,000 (-43.03%)

$13,881,000 (-24.92%)

$18,489,000 (-57.66%)

$43,669,000 (253.14%)

Tangible Asset Value

$13,660,000 (-33.29%)

$20,478,000 (-6.95%)

$22,007,000 (-54.61%)

$48,481,000 (196.68%)

Market Capitalization

$49,831,664 (259.95%)

$13,844,202 (28.63%)

$10,762,596 (-78.89%)

$50,983,878 (20.49%)

Average Equity

$85,494,750 (150.42%)

$34,140,500 (28.77%)

$26,511,750 (-49.87%)

$52,890,500 (314.48%)

Average Assets

$93,749,750 (150.04%)

$37,494,500 (21.67%)

$30,816,000 (-46.04%)

$57,112,750 (168.52%)

Invested Capital Average

-$3,887,250 (-491.27%)

$993,500 (-95.10%)

$20,292,000 (-52.78%)

$42,969,750 (364.17%)

Shares

21,665,941 (377.10%)

4,541,167 (-0.00%)

4,541,180 (0.28%)

4,528,680 (122.62%)